default author photo

Maria Isabel Achatz

Hospital Sirio-Libanes

Brazil

SCHOLARLY PAPERS

3

DOWNLOADS

189

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

Tumor Spectrum and Temporal Cancer Trends in Adult Carriers of Li-Fraumeni Syndrome: Implications for Personalized Screening Strategies in TP53 R337H Carriers

Number of pages: 29 Posted: 03 Apr 2024
Hospital Sirio-Libanes, Hospital Sirio-Libanes, Hospital Sirio-Libanes, Hospital Sirio-Libanes, Hospital Sirio-Libanes, Oncologia D’Or, Hospital Israelita Albert Einstein, Hospital de Clínicas de Porto Alegre (HCPA), Hospital Universitário Cassiano Antonio Moraes (HUCAM), University Grenoble-Alpes, Institute for Advanced Study, affiliation not provided to SSRN and Hospital Sirio-Libanes
Downloads 94 (720,278)
Citation 1

Abstract:

Loading...

Li-Fraumeni Syndrome, TP53 mutations, Cancer spectrum and risk, R337H variant, Genomics

2.

Cancer Surveillance for Patients with Li-Fraumeni Syndrome in Brazil is Cost-Effective

Number of pages: 27 Posted: 10 Nov 2021
Massachusetts Institute of Technology, Centro Universitário de João Pessoa, University of Utah - College of Pharmacy and Hospital Sirio-Libanes
Downloads 54 (1,020,567)
Citation 1

Abstract:

Loading...

Li-Fraumeni Syndrome, cost-effectiveness, TP53, cancer surveillance

3.

A Brazilian Li-Fraumeni Germline Pathogenic Variant Promotes Aggregation of p53 in cancer cells extracted from a mastectomy surgery

Number of pages: 90 Posted: 15 Jan 2026
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Universidade Federal do Triângulo Mineiro, affiliation not provided to SSRN, Hospital Sirio-Libanes, affiliation not provided to SSRN, Universidade Federal do Rio de Janeiro (UFRJ) - Programa de Biologia Estrutural and Universidade Federal do Rio de Janeiro (UFRJ) - Programa de Biologia Estrutural
Downloads 41 (1,209,354)

Abstract:

Loading...

Cancer, tumor-suppressor p53, Aggregation, Li-Fraumeni